FDA Revokes Emergency Use Authorization for Chloroquine and
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The Food and Drug Administration has revoked its emergency use authorization for the drugs hydroxychloroquine and chloroquine for the treatment of Covid-19.

• Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that CQ and HCQ are unlikely to be effective in treating COVID-19.

• Additionally, in light of ongoing serious cardiac adverse events and other potentially serious side effects, the known and potential benefits of these drugs no longer outweigh the known and potential risks for the authorized use.

• Recent results from a large randomized clinical trial in hospitalized patients demonstrated that HCQ showed no benefit on mortality or in speeding recovery.

• CQ and HCQ are both FDA-approved to treat or prevent malaria. HCQ also approved to treat autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis.

• FDA has determined that these drugs are safe and effective when used for these diseases in accordance with their FDA-approved labeling.

• Of note, FDA approved products may be prescribed by physicians for off-label uses if they determine it is appropriate for treating their patients, including during COVID.

Source: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and
Dr. T●●●●z H●●●●●●i and 7 others like this8 shares
Like
Comment
Share
Dr. De P●●●●p
Dr. De P●●●●p General Medicine
And this goes on.
Jun 16, 2020Like